| Telemedicine in the Management of Pain in Patients With Advanced or Metastatic Pancreatic Cancer (NCT04667403) | Institut Cancerologie de l'Ouest | 2022-02-07 |
| A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab (NCT07280377) | Oncolytics Biotech | 2021-10-27 |
| Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma (NCT05047991) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2021-10-01 |
| Safety Study of Whole Body Hyperthermia for Advanced Cancer (NCT04467593) | ElmediX | 2021-07-28 |
| PanDox: Targeted Doxorubicin in Pancreatic Tumours (NCT04852367) | University of Oxford | 2021-06-16 |
| RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic Cancer (NCT04338763) | Rise Biopharmaceuticals, Inc. | 2021-04-19 |
| A Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety of Anti-PD1 Antibody (Camrelizumab) Combined With Paclitaxel(Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer (NCT04674956) | RenJi Hospital | 2021-03-04 |
| Pancreatic Adenocarcinoma Signature Stratification for Treatment (NCT04469556) | University Health Network, Toronto | 2020-10-14 |
| INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer (NCT04116073) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-04-09 |
| Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer (NCT03984214) | Arbeitsgemeinschaft medikamentoese Tumortherapie | 2019-12-16 |
| Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas (NCT03504423) | Cornerstone Pharmaceuticals | 2018-11-09 |
| Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer (NCT03412799) | Panbela Therapeutics, Inc. | 2018-06-04 |
| Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial (NCT04721301) | University Hospital Heidelberg | 2017-01-15 |
| A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy (NCT02959151) | Shanghai GeneChem Co., Ltd. | 2016-07-01 |
| Phase II Study of 5-FU, Oxaliplatin Plus Dasatinib in Metastatic Pancreatic Adenocarcinoma (NCT01652976) | University of Florida | 2012-07-01 |
| Does Recurrent Pancreatic Cancer Really Have Similar Outcome Compared With Primary Metastatic Pancreatic Cancer? (NCT06921252) | Kochi University | 2010-01-01 |
| Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma (NCT07573215) | Revolution Medicines, Inc. | |
| OSI-906 With Gemcitabine and Erlotinib for Metastatic Ductal Adenocarcinoma of the Pancreas (NCT01600807) | Dana-Farber Cancer Institute | |